Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
LONDON, March 10, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") VRAX, an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, announced today the closing …